| Allied Professional Program |
| Allied Professional Program 1 - Basic electrophysiology |
| ECG for allied professionals |
Dhillon Harbinder KAUR |
Hong Kong |
View |
| Tachy-arrhythmias |
Kwok-Keung CHAN |
Hong Kong |
View |
| Brady-arrhythmias |
Michael KL WONG |
Hong Kong |
View |
| Non-invasive investigations of rhythm disorders |
Warren WL WONG |
Hong Kong |
|
| Chain of survival |
Wai-Ming CHAN |
Hong Kong |
|
| |
| Allied Professional Program 2 - Basic Devices |
| Cardioversion and tilt table testing: nursing perspectives |
Wai-Sum LUK |
Hong Kong |
|
| Catheter ablation: principles and application |
Frank LY TAM |
Hong Kong |
|
| Anti-arrhythmias drugs |
Hamish CK CHAN |
Hong Kong |
|
| Electrophysiology study: when, why and how? |
Man-Chun CHOI |
Hong Kong |
|
| Overview of implantable cardiac devices |
Pak-Hei CHAN |
Hong Kong |
|
| |
| Allied Professional Program 3 - Advanced Electrophysiology |
| Application of cryoablation |
Ngai-Yin CHAN |
Hong Kong |
View |
| Overview of Ensite mapping |
Wing-Hong FUNG |
Hong Kong |
|
| Techniques of transeptal puncture |
Boron CW CHENG |
Hong Kong |
|
| Cardiac anatomy and the conduction system |
Jo-Jo HAI |
Hong Kong |
|
| Overview of CARTO mapping |
Shawn Byung Chan LEE |
Singapore |
|
| |
| Allied Professional Program 4 - Advanced devices |
| Implantation and follow up of pacemakers |
Sum-Kin LEUNG |
Hong Kong |
|
| Remote monitoring of implantable cardiac devices |
Yiu-Kwan KO |
Hong Kong |
|
| Implantation and follow up of ICD |
Cathy TF LAM |
Hong Kong |
|
| Conscious sedation in the EP lab |
Chi-Wai CHEUNG |
Hong Kong |
|
| Implantation and follow up of CRT devices |
Ho-Chuen YUEN |
Hong Kong |
|
| Atrial Fibrillation Ablation |
| Atrial Fibrillation Ablation 1 - Catheter Ablation of Atrial Fibrillation: State of the Art |
| Cather ablation of paroxysmal atrial fibrillation current technique, success, and complications |
Chong FENG |
China |
|
| Guideline recommendations for AF ablation: what is new? |
Hugh CALKINS |
USA |
|
| Mapping rotors: scientific interest or clinical tool |
Meleze HOCINI |
France |
|
| The scientific basis of AF ablation: why does it work? |
Peng-Sheng CHEN |
USA |
|
| Catheter ablation of long standing persistent atrial fibrillation current technique (success (and complications |
Shih-Ann CHEN |
Taiwan |
|
| |
| Atrial Fibrillation Ablation 2 - Technical Aspects of Ablation Tools |
| How to identify rotors? |
Carlo PAPPONE |
Italy |
|
| Value and pitfalls of image integration |
Chang-Sheng MA |
China |
|
| How to maximize the value of ICE imaging? |
Gary CP CHAN |
Hong Kong |
|
| How to prevent an atrial esophageal fistula? |
Hugh CALKINS |
USA |
|
| How to maximize the value of force sensing ablation catheters |
Karl-Heinz KUCK |
Germany |
|
| |
| Atrial Fibrillation Ablation 3 - Technical Aspects of AF Ablation |
| How to achieve permanent PV isolation using the cryoballoon |
Ngai-Yin CHAN |
Hong Kong |
View |
| How to safely perform a transseptal puncture without ICE |
Chen-Yang JIANG |
China |
|
| How to present stroke and asymptomatic cerebral emboli during AF ablation |
Hugh CALKINS |
USA |
|
| How to map and ablate left atrial flutter post AF ablation |
Hui-Nam PAK |
South Korea |
|
| How to achieve permanent PV isolation using RF energy |
Yun-Long XIA |
China |
|
| |
| Atrial Fibrillation Ablation 4 - Important Questions in the Field of AF Ablation? |
| Should AF termination be the endpoint during ablation of long standing persistent AF? |
Jian-Zeng DONG |
China |
View |
| Does contact force monitoring improve outcomes of AF ablation? |
Karl-Heinz KUCK |
Germany |
View |
| Can anticoagulation be stopped 2 months post successful ablation in a patient with a high stroke risk? |
Jo-Jo HAI |
Hong Kong |
|
| Does targeting CFAEs improve outcomes of ablation or is this the wrong target? |
Jonathan KALMAN |
Australia |
|
| Can AF ablation be performed safely in a patient on a NOAC without interruption? |
Yenn-Jiang LIN |
Taiwan |
|
| |
| Atrial Fibrillation Ablation Workshop 1 - Progress in Ablation of AF |
| Ganglionated plexi ablation: appraisal of risks and benefits |
Yasuo OKUMURA |
Japan |
View |
| Extracorporeal carbon particle therapy for ablating atrial arrhythmias |
Douglas PACKER |
USA |
|
| New generation high output/alternative energy sources for the ablation of AF |
Karl-Heinz KUCK |
Germany |
|
| Innovations in EP mapping and ablation catheters |
Peter CHEN |
USA |
|
| High-density mapping and ablation of complex atrial tachyardia |
Yumei XUE |
China |
|
| |
| Atrial Fibrillation Ablation Workshop 2 - A New Generation of Approaches |
| The biophysics of new generation cryoballoon and contact force ablative intervention |
Ngai-Yin CHAN |
Hong Kong |
View |
| Pulmonary antrum radial-linear ablation |
Xue ZHAO |
China |
|
| Impact of contact force ablation on clinical outcomes in patients with atrial fibrillation |
Chang-Sheng MA |
China |
|
| 4-5 D mapping for ablation of AF rotors to drivers |
Douglas PACKER |
USA |
|
| Linear cold balloon therapy for persistent atrial fibrillation |
FeiFan OUYANG |
Germany |
|
| Atrial Fibrillation Device |
| Atrial Fibrillation Devicev 1 - AF and CIEDS |
| Prognostic importance of AF among ICD patients |
Kazuo MATSUMOTO |
Japan |
View |
| Role of loop-recorder in evaluation of cryptogenic stroke |
Ngai-Yin CHAN |
Hong Kong |
View |
| What is the prognostic importance of AF documented on device datalogs |
Chu-Pak LAU |
Hong Kong |
View |
| Role of ATP and MVP in preventing AF |
Luigi PADELETTI |
Italy |
|
| |
| Atrial Fibrillation Device 2 - How to Manage AF Patients with Devices |
| Optimize ICD device programming to avoid inappropriate AF shocks |
David CANNOM |
USA |
View |
| When to anticoagulate asymptomatic AF on device datalogs |
John IP |
USA |
View |
| Optimizing CRT function among patients with AF |
Anil SAXENA |
India |
|
| When to choose AF ablation vs AV node ablation vs amiodarone in ICD subjects |
Cathy TF LAM |
Hong Kong |
|
| How best to manage anticoagulation during CIED procedures |
Gregory LIP |
United Kingdom |
|
| When to perform AV node ablation in CRT patients with Afib |
Yuji NAKAZATO |
Japan |
|
| Atrial Fibrillation Drug |
| Atrial Fibrillation Drug - Focus Session - the Good, the Bad and the Ugly |
| Rate control with digoxin: safe or not? |
A John CAMM |
United Kingdom |
View |
| Drugs for pharmacological cardioversion: the old, the new and the future |
David BENDITT |
USA |
View |
| Stroke prevention in atrial fibrillation: pharmacological and non-pharmacological approaches |
Gregory LIP |
United Kingdom |
|
| What or who are we treating? |
Jiunn-Lee LIN |
Taiwan |
|
| Sinus conversion of persistent AF by Bepridil |
Yuji NAKAZATO |
Japan |
|
| |
| Atrial Fibrillation Drug 1 - Managing Atrial Fibrillation in 2014: From Guidelines to Clinical Practice |
| New guidelines, new challenges |
A John CAMM |
United Kingdom |
View |
| Screening and detection |
David CW SIU |
Hong Kong |
View |
| Electrophysiology - what's new |
Eric PRYSTOWSKY |
USA |
|
| Stroke prevention |
Gregory LIP |
United Kingdom |
|
| Rate control, rhythm control, or both |
Wee-Siong TEO |
Singapore |
|
| |
| Atrial Fibrillation Drug 2 - How to Use NOACs for Stroke Prevention in Atrial Fibrillation: Practical Tips |
| Do we need to treat Asian patients differently |
Ken OKUMURA |
Japan |
View |
| Choosing the right NOAC for the right patient: One drug for all? |
Chern-En CHIANG |
Taiwan |
|
| The patient presenting with an acute coronary syndrome and/or requiring stenting |
Bryan PY YAN |
Hong Kong |
|
| Ensuring compliance and treatment adherence |
Gregory LIP |
United Kingdom |
|
| The patient who is bleeding or requiring surgery: Is a NOAC antidote needed |
Li-Qun WU |
China |
|
| CSPE |
| CSPE Session 1 - EP Part |
| Left atrial appendage occlusion in China |
He HUANG |
China |
View |
| Accelerated ventricular rhythm from His-purkinje system: benign or insidious? |
Ming-Long CHEN |
China |
View |
| SCN5a screening might predispose to VT/VF after lidocaine administration in the setting of myocardial ischemia |
Kui HONG |
China |
|
| The value of high density mapping and contact force monitoring on radiocartheter ablation of AF |
Yan YAO |
China |
|
| Cryoablation for treatment of paroxysmal atrial fibrillation: experience from RuiJin Hosptial |
Li-Qun WU |
China |
|
| |
| CSPE Session 2 - Anticoagulation of AF |
| Do the subclinical atrial fibrillation recorded by pacemaker need antithrombotic therapy? |
Jian-Zeng DONG |
China |
View |
| Antithrombotic therapy for the atrial fibrillation in patients with acute coronary syndrome |
Xinchun YANG |
China |
View |
| Antithrombotic therapy for the atrial fibrillation patients in perioperative or postoperative period of radiofrequency ablation |
Bo YANG |
China |
|
| The present situation and problems of atrial fibrillation anticoagulation in China |
Chang-Sheng MA |
China |
|
| Application of new oral anticoagulant for patients with non-valvular atrial fibrillation - consensus of Chinese experts |
De-Jia HUANG |
China |
|
| |
| CSPE Session 3 - Implanted Device |
| The developments in cardiac-pacing in China |
Wei HUA |
China |
View |
| The application of cardiac implantable devices in China--2014 |
Shu ZHANG |
China |
|
| Primary prevention of sudden cardiac death--China Registry |
De-Jia HUANG |
China |
|
| Progress of cardiac contractility modulation in the therapy of heart failure |
Fa-Rong SHEN |
China |
|
| The application of remote monitoring of cardiac pacemaker in China |
Jiefu YANG |
China |
|
| If the CRT based on the pace-making of left ventricle can bring additional benefits |
Xiaoling XUE |
China |
|
| |
| CSPE Session 4 - Sudden Cardiac Death |
| Risk of sudden death in hypertrophic cardiomyopathy and ICD therapy |
Jing-Feng WANG |
China |
View |
| Predictive factors of sudden cardiac death for post myocardial infarction patients with heart failure |
Wei HUA |
China |
View |
| Research progress on hereditary arrhythmia |
Kui HONG |
China |
|
| Progress in treatment of idiopathic ventricular fibrillation |
Hong JIANG |
China |
|
| Prevention of sudden cardiac death in non-ischemic cardiomyopathy |
Ji YAN |
China |
|
| Treatment for arrhythmogenic cardiomyopathy: RFCA or ICD? |
Ming-Long CHEN |
China |
|
| HF Device & Monitoring |
| HF Device & Monitoring 1 - Optimization of CRT |
| RV function in CRT |
David BENDITT |
USA |
View |
| Effect of lead position on clinical outcome |
Bruce STAMBLER |
USA |
|
| Impact of QRS duration and morphology on CRT effectiveness |
Cheuk-Man YU |
Hong Kong |
|
| Role of MRI for CRT |
Ming-Yen NG |
Hong Kong |
|
| Novel LV lead placement |
Pierre BORDACHAR |
France |
|
| |
| HF Device & Monitoring 2 - Advances in CRT Therapy |
| Predictors of mortality and cardiovascular mortality after CRT |
Bo YANG |
China |
|
| Left ventricular endocardial leadless pacing |
Chu-Pak LAU |
Hong Kong |
View |
| Expanding indications of CRT |
Fang FANG |
Hong Kong |
|
| Antiarrhythmic effects of CRT with triple biventricular stimulation |
Michio OGANO |
Japan |
|
| Electromechanical guidance to CRT |
Pierre BORDACHAR |
France |
|
| |
| HF Device & Monitoring 3 |
| Endocardio LV pacing |
Pierre BORDACHAR |
France |
View |
| Remote monitoring of patients with ICDs and heart failure |
Edmund KEUNG |
USA |
|
| Optimal programming to reduce ICD shocks |
Katherine FAN |
Hong Kong |
|
| Avoidance of phrenic nerve stimulation in CRT |
Kenneth ELLENBOGEN |
USA |
|
| Optimization of AV intervals |
Muhammad MUNAWAR |
Indonesia |
|
| ICD |
| ICD - Focus Session - ICD and Atrial Fibrillation |
| Chronotropic incompetence and rate control |
Bruce WILKOFF |
USA |
View |
| Device choice and programming |
Chun-Chieh WANG |
Taiwan |
|
| Atrial fibrillation and AV junction ablation for ICD and CRT patients |
Dong-Gu SHIN |
South Korea |
|
| Management of anticoagulation |
Ken OKUMURA |
Japan |
|
| Impact of atrial fibrillation on outcomes |
Wee-Siong TEO |
Singapore |
|
| |
| ICD 1 - ICD Implant Related Issues |
| Implanting to minimize complications |
Bo YU |
China |
|
| Incidence (recognition and therapy of ICD infections |
Bruce WILKOFF |
USA |
|
| Morbidity and mortality impact of ICD therapy: short and long term |
David CANNOM |
USA |
|
| Follow leads with and without reliability issues |
Kenneth ELLENBOGEN |
USA |
|
| When and how to test defibrillation |
Yong-Seog OH |
South Korea |
|
| |
| ICD 2 - Tachycardia Device Outcomes |
| When and how to use subcutaneous ICD therapy |
Arthur WILDE |
Netherlands |
View |
| CIED deactivation |
Chu-Pak LAU |
Hong Kong |
View |
| ICD programming to improve outcomes |
Wanwarang WONGCHAROEN |
Thailand |
View |
| Risk stratification for primary prevention |
Shu ZHANG |
China |
|
| Creative and alternative venous access for implantation |
Morio SHODA |
Japan |
|
| Lead Management / Extraction |
| Lead Management/ Extraction Workshop 1 - Infection and Extraction |
| Prevention and Innovations in CIED Infection Management |
Charles KENNERGREN |
Sweden |
View |
| Extraction approaches to infected devices |
Xue-Bin LI |
China |
|
| Best practices in prevention and treatment of infections |
Chun-Chieh WANG |
Taiwan |
|
| Incidence, risks and detection of device infection |
Kenneth ELLENBOGEN |
USA |
|
| Outcomes of patients with device infections |
Nigel LEVER |
New Zealand |
|
| |
| Lead Management / Extraction Workshop 2 |
| When and how each tool is useful |
Bruce WILKOFF |
USA |
View |
| Managing vegetations in device patients |
Charles KENNERGREN |
Sweden |
View |
| Knowing when to say no or stop |
Hung-Fat TSE |
Hong Kong |
|
| Coronary sinus lead extraction |
Morio SHODA |
Japan |
|
| Trans femoral approach of Lead extraction |
Nigel LEVER |
New Zealand |
|
| Practical Arrhythmia Management for Clinicians |
| Practical Arrhythmia Management for Clinicians 1 - ECG and Case Studies: How to Approach Such Arrhythmia?arrhythmia? |
| ECG interpretation |
Chu-Pak LAU |
Hong Kong |
View |
| Narrow complex tachycardia |
Kwok-Keung CHAN |
Hong Kong |
View |
| Wide complex tachycardia |
Ruey SUNG |
USA |
View |
| Bradycardia |
Jiunn-Lee LIN |
Taiwan |
|
| |
| Practical Arrhythmia Management for Clinicians 2 - How would you Manage this Patient? |
| A cancer patient with an ICD |
John IP |
USA |
|
| Who and when should you refer for AF ablation? |
Kathy LF LEE |
Hong Kong |
|
| An elderly patient who fainted |
Richard SUTTON |
Monaco |
|
| A patient with palpitation and tones of ectopics |
Venkat THOLAKANAHALLI |
USA |
|
| |
| Practical Arrhythmia Management for Clinicians 3 - Update on Implantable Cardiac Devices |
| Contemporary implantable cardiac electronic devices |
Ruth KAM |
Singapore |
|
| Recent advances in implantable defibrillator |
David CANNOM |
USA |
|
| Recent advances in bradycardia pacing |
Harry MOND |
Australia |
|
| Recent advances in cardiac resynchronization therapy |
Ho-Chuen YUEN |
Hong Kong |
|
| |
| Practical Arrhythmia Management for Clinicians 4 - Atrial Fibrillation |
| Who needs antithrombotic treatment? |
Chern-En CHIANG |
Taiwan |
|
| A sleep apnea patient with cardiomegaly |
Kai-Hang YIU |
Hong Kong |
|
| How to deal with a patient on novel anticoagulant when they develop other medical issues? |
Kai-Hang YIU |
Hong Kong |
|
| How to decide on rate or rhythm control? |
A John CAMM |
United Kingdom |
|
| Sponsored Symposia |
| Sponsored Symposia - Biosense Webster - Back to Zero EP course 1 |
| Anatomic understanding and catheter manipulation in SVTs |
Chen-Yang JIANG |
China |
|
| Differentiate diagnosis for complex SVTs |
Wee-Siong TEO |
Singapore |
|
| |
| Sponsored Symposia - Biosense Webster - Back to Zero EP course 2 |
| Ablation index and biophysics |
Yan YAO |
China |
|
| How to reduce fluoroscopy in SVTs with new techniques |
Yan YAO |
China |
|
| |
| Sponsored Symposia - BIOTRONIK Lunch Symposium - Advancing the Standard of Care for Patients with the use of Novel Technologies |
| Practical approaches in the management of ICD patients with BIOTRONIK home monitoring |
Ruth KAM |
Singapore |
|
| AF management with BIOTRONIK DX system |
Jo-Jo HAI |
Hong Kong |
|
| |
| Sponsored Symposia - Boehringer Ingelheim Lunch Symposium |
| Evidences of NOACs in SPAF: past, present and future |
Hung-Fat TSE |
Hong Kong |
|
| Stroke management in NOAC patients: from acute presentation to recovery |
Yannie SOO |
Hong Kong |
|
| |
| Sponsored Symposia - Boston Scientific Lunch Symposium |
| Subcutaneous ICD: simplicity in complexity |
Chi-Keong CHING |
Singapore |
|
| True tip location ablation with MiFi™ micro fidelity electrodes |
Hung-Fat TSE |
Hong Kong |
|
| |
| Sponsored Symposia - Medtronic - Radiology and MRI Implantable Cardiac Devices Symposium |
| MRI conditional device update |
Michael HILL |
USA |
View |
| Cardiologist perspective |
Carmen CHAN |
Hong Kong |
|
| MRI conditional device programming pre/post MRI |
Medtronic Specialist |
Hong Kong |
|
| Radiologist perspective |
Stephen CW CHEUNG |
Hong Kong |
|
| |
| Sponsored Symposia - Medtronic Atrial Fibrillation Symposium |
| AF ablation with 2nd generation cryoballoon |
Ngai-Yin CHAN |
Hong Kong |
View |
| Early experience of cryoablation in China |
Pi-Hua FANG |
China |
View |
| Tips and tricks of using 1st generation cryoballoon |
Xian-Hong FANG |
China |
|
| |
| Sponsored Symposia - Medtronic SCA Lunch Symposium |
| Role of MRI conditional ICDs |
Michael HILL |
USA |
View |
| Global improve SCA trial |
Shu ZHANG |
China |
|
| SCA patient pathway protocol |
Chi-Keong CHING |
Singapore |
|
| |
| Sponsored Symposia - Merck Sharp & Dohme Cocktail Reception and Evening Symposium |
| Sharing the APHRS guideline on anticoagulation in AF |
Chu-Pak LAU |
Hong Kong |
View |
| Lowering CV risk- how low can you go? |
Shu-Kin LI |
Hong Kong |
|
| |
| Sponsored Symposia - St. Jude Medical Dinner Symposium - AF & VT Ablation Technologies |
| Future imaging technologies (Integrated Lab) |
Philipp SOMMER |
Germany |
|
| Strategy for complex arrhythmia ablation (Precision) |
Shih-Ann CHEN |
Taiwan |
|
| |
| Sponsored Symposia - St. Jude Medical Lunch Symposium - The Future of Device Management |
| Leadless pacing |
Carsten ISRAEL |
Germany |
|
| CRT MultiPoint pacing - reducing non-responder rates |
Carlo PAPPONE |
Italy |
|
| Remote disease management (clinical data review) |
Edmund KEUNG |
USA |
|
| Sudden Cardiac Death |
| Sudden Cardiac Death - Focus Session - State of the Art for Familial Arrhythmia Syndromes: Long QT, Brugada, CPVT, HCM, ARVD |
| Clinical approach to genetic testing and counselling |
Arthur WILDE |
Netherlands |
View |
| Risk markers on the 12-lead ECG |
Ken OKUMURA |
Japan |
View |
| Role of drug therapy |
Mohan NAIR |
India |
View |
| |
| Sudden Cardiac Death - Sudden Cardiac Death Symposium (Supported by unrestricted grant from Hong Kong Heart Foundation & Wei Lun Foundation Ltd.) |
| In non-ischemic cardiomyopathy |
Wing-Hong FUNG |
Hong Kong |
|
| Following acute myocardial infarction |
Karl-Heinz KUCK |
Germany |
|
| Assessing risk of SCD in the young athlete |
Kit CHAN |
Hong Kong |
|
| Exercise prescription for patients at established high risk |
Leonard LI |
Hong Kong |
|
| Rising burden of pulseless electrical activity: causes and implications |
Sumeet CHUGH |
USA |
|
| |
| Sudden Cardiac Death - Ventricular Arrhythmias in the General Population |
| Asian sudden cardiac death in heart failure (ASIAN-HF) registry |
Carolyn LAM |
Singapore |
|
| Gender differences in risk and prevention |
Hygriv RAO |
India |
|
| Implications of the obesity and diabetes epidemics |
Priya CHOCKALINGAM |
India |
|
| Role of risk markers using exercise testing in clinical workup for arrhythmias |
Takanori IKEDA |
Japan |
|
| VT Ablation |
| VT Ablation 1 - Outcome of VT Ablation |
| Role of the NIPS (non-invasive programmed stimulation via the ICD) |
Carsten ISRAEL |
Germany |
View |
| Programmed stimulation results and their relation to long term survival |
Karl-Heinz KUCK |
Germany |
View |
| Epicardial and ablation techniques for VTs |
Young-Hoon KIM |
South Korea |
View |
| Mapping and ablation of intra-septal / intra mural VTs |
Venkat THOLAKANAHALLI |
USA |
|
| Endpoint of VT ablation |
Yenn-Jiang LIN |
Taiwan |
|
| |
| VT Ablation 2 |
| Catheter ablation for PMVT/VF |
Akihiko NOGAMI |
Japan |
|
| Tips and tricks for epicardial puncture |
Hyung-Wook PARK |
South Korea |
|
| Role of unipolar mapping in ventricular outflow track arrhythmia |
Chang-Sheng MA |
China |
|
| How to deal with fascicular VTs? |
Shibu MATHEW |
Germany |
|
| Precise location of ventricular outflow tract arrhythmias base on 12-lead ECG |
Xing-Peng LIU |
China |
|
| |
| VT Ablation 3 |
| New technology for intramural VTs |
Philipp SOMMER |
Germany |
View |
| Substrate based techniques only during sinus rhythm: how reliable is this? |
Yong-Seog OH |
South Korea |
View |
| Mapping of Brugada syndrome |
Carlo PAPPONE |
Italy |
|
| Management of hemodynamic unstable VTs |
Chi-Keong CHING |
Singapore |
|
| Strategies for substrate ablation: homogenization, LAVA/late potentials, linear lesions? |
Meleze HOCINI |
France |
|
